PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 28, 2026Infectious Diseases and Therapy3 citationsOpen Access

Clinical Outcomes Among Older Adults Hospitalized with Respiratory Syncytial Virus and Influenza Infection: A Retrospective Analysis

MJMenucha JurkowiczTel Aviv UniversityIMIli MargalitTel Aviv UniversityIHItai HarrisTel Aviv University

Key Points

  • This study aims to analyze clinical outcomes of older adults hospitalized with RSV compared to those with influenza.
  • Conducted a retrospective analysis in hospitalized adults aged ≥ 60 years with confirmed RSV or influenza.
  • Utilized RT-PCR for virus confirmation and recorded primary outcomes including ICU admission and mortality.
  • Applied inverse probability treatment weighting to adjust for confounding variables.
  • Among RSV-positive patients, 30-day and 90-day mortality rates were 11.9% and 18.8%, respectively.
  • ICU admission occurred in 10.6% of RSV cases, with mechanical ventilation in 6.4% and vasopressor support in 6.5%.
  • RSV infection showed a trend towards increased risk for poor clinical outcomes compared with influenza.

Abstract

Respiratory syncytial virus (RSV) is a major cause of morbidity and mortality among older adults. Limited information is available in Israel regarding RSV outcomes, particularly compared to influenza, to guide strategies for RSV vaccination. This study aimed to characterize RSV infection and predictors of clinical outcomes among hospitalized adults aged ≥ 60 years in Israel between 2016 and 2023, and to compare disease severity and outcomes with those of seasonal influenza hospitalizations. A retrospective analysis was conducted of hospitalized adults aged ≥ 60 years with positive RSV or influenza confirmed via standard-of-care RT-PCR between 2016 and 2023. The primary outcome was a composite of intensive care unit (ICU) admission, mechanical ventilation, vasopressor support, or 30-day mortality. Cardiovascular complications were recorded. An inverse probability treatment weighting (IPTW) was used to adjust for potential confounding. Weighted and unweighted relative risks (RRs) were estimated to compare clinical outcomes between RSV and influenza. Overall, 817 RSV-positive and 2113 influenza-positive patients were included. Among patients with RSV, 30-day and 90-day mortality rates were 11.9% and 18.8% respectively; ICU admission was required for 10.6%, mechanical ventilation for 6.4%, and vasopressor support for 6.5%. Tachyarrhythmia was documented in 17.7% and ischemia in 9.9%. Predictors of the composite primary outcome included chronic pulmonary disease, lower respiratory tract infection, hypothermia, elevated pulse, lower blood pressure and increased creatinine. In IPTW-adjusted analyses, RSV infection had a trend for increased risk for the composite primary outcome (RR 1.03, 95% confidence interval CI 1.00, 1.06) and 90-day mortality (RR 1.02, 95% CI 0.99, 1.05) compared with influenza. Among hospitalized older adults, RSV infection carries considerable morbidity and mortality and may have a higher risk for poor clinical outcomes compared with influenza. These findings support the prioritization of RSV vaccination programs among older adults.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Jurkowicz et al. (2026) studied this question.

synapsesocial.com/papers/69c7724e8bbfbc51511e2b6bhttps://doi.org/10.1007/s40121-025-01295-z
Ask AI
Helpful
Bookmark
Share
View Full Paper